Search research articles
Contact Us
Filters
Showing results (191-200 of 194) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 194 results.
Journal of Appalachian Health
|
June 30, 2022
Barn-Raising on the Digital Frontier: The L.A.U.N.C.H. Collaborative
Bradford W Hesse, David Ahern, Michele Ellison, et al.
Nature Methods
|
June 15, 2018
Author Correction: Informed-Proteomics: open-source software package for top-down proteomics
Jungkap Park, Paul D Piehowski, Christopher Wilkins, et al.
Science (New York, N.Y.)
|
July 17, 2012
Clovis age Western Stemmed projectile points and human coprolites at the Paisley Caves
Dennis L Jenkins, Loren G Davis, Thomas W Stafford, et al.
Nature Aging
|
February 20, 2026
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease
M H Werner, A McGarry, C Meyer, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 194) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 194 results.
Journal of Appalachian Health
|
June 30, 2022
Barn-Raising on the Digital Frontier: The L.A.U.N.C.H. Collaborative
Bradford W Hesse, David Ahern, Michele Ellison, et al.
Nature Methods
|
June 15, 2018
Author Correction: Informed-Proteomics: open-source software package for top-down proteomics
Jungkap Park, Paul D Piehowski, Christopher Wilkins, et al.
Science (New York, N.Y.)
|
July 17, 2012
Clovis age Western Stemmed projectile points and human coprolites at the Paisley Caves
Dennis L Jenkins, Loren G Davis, Thomas W Stafford, et al.
Nature Aging
|
February 20, 2026
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease
M H Werner, A McGarry, C Meyer, et al.
Page
of 20